Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Biometals ; 29(3): 543-50, 2016 06.
Article in English | MEDLINE | ID: mdl-27138944

ABSTRACT

Organoseleno-compounds have been investigated for its beneficial effects against methylmercury toxicity. In this way, diphenyl diselenide (PhSe)2 was demonstrated to decrease Hg accumulation in mice, protect against MeHg-induced mitochondrial dysfunction, and protect against the overall toxicity of this metal. In the present study we aimed to investigate if co-treatment with (PhSe)2 and MeHg could decrease accumulation of Hg in liver slices of rats. Rat liver slices were co-treated with (PhSe)2 (0.5; 5 µM) and/or MeHg (25 µM) for 30 min at 37 °C and Se and Hg levels were measured by inductively coupled plasma mass spectrometry (ICP-MS) in the slices homogenate, P1 fraction, mitochondria and incubation medium. Co-treatment with (PhSe)2 and MeHg did not significantly alter Se levels in any of the samples when compared with compounds alone. In addition, co-treatment with (PhSe)2 and MeHg did not decrease Hg levels in any of the samples tested, although, co-incubation significantly increased Hg levels in homogenate. We suggest here that (PhSe)2 could exert its previously demonstrated protective effects not by reducing MeHg levels, but forming a complex with MeHg avoiding it to bind to critical molecules in cell.


Subject(s)
Benzene Derivatives/pharmacology , Liver/chemistry , Liver/drug effects , Mercury/analysis , Methylmercury Compounds/pharmacology , Organoselenium Compounds/pharmacology , Selenium/analysis , Animals , Benzene Derivatives/administration & dosage , Male , Mass Spectrometry , Methylmercury Compounds/administration & dosage , Mitochondria, Liver/chemistry , Mitochondria, Liver/drug effects , Mitochondria, Liver/metabolism , Organoselenium Compounds/administration & dosage , Rats , Rats, Wistar
2.
Toxicol Rep ; 3: 351-356, 2016.
Article in English | MEDLINE | ID: mdl-28959556

ABSTRACT

The effect of the antioxidant gallic acid (GA) on Pb toxicity in blood, liver and kidney was investigated in the present study. Rats Wistar received Pb nitrate (50 mg/Kg/day, i.p., 5 days) followed by GA (13.5 mg/Kg, p.o., 3 days) or a chelating agent (EDTA, 55 mg/Kg, i.p.). As result, Pb decreased body weight, hematocrit and blood δ-aminolevulinic acid dehydratase (ALA-D) activity. In addition, high Pb levels were observed in blood and tissues, together with increased (1) lipid peroxidation in erythrocytes, plasma and tissues, (2) protein oxidation in tissues and (3) plasma aspartate transaminase (AST) levels. These changes were accompanied by decreasing in antioxidant defenses, like superoxide dismutase (SOD) activity in tissues and catalase (CAT) activity and reduced glutathione (GSH) in liver. GA was able to reverse Pb-induced decrease in body weight and ALA-D activity, as well as Pb-induced oxidative damages and most antioxidant alterations, however it did not decrease Pb bioaccumulation herein as EDTA did. Furthermore, EDTA did not show antioxidant protection in Pb-treated animals as GA did. In conclusion, GA decreased Pb-induced oxidative damages not by decreasing Pb bioaccumulation, but by improving antioxidant defenses, thus GA may be promising in the treatment of Pb intoxications.

3.
Toxicol Lett ; 203(1): 74-81, 2011 May 30.
Article in English | MEDLINE | ID: mdl-21402136

ABSTRACT

We investigated the antioxidant potential of gallic acid (GA), a natural compound found in vegetal sources, on the motor and oxidative damages induced by lead. Rats exposed to lead (50 mg/kg, i.p., once a day, 5 days) were treated with GA (13.5mg/kg, p.o.) or EDTA (110 mg/kg, i.p.) daily, for 3 days. Lead exposure decreased the locomotor and exploratory activities, reduced blood ALA-D activity, and increased brain catalase (CAT) activity without altering other antioxidant defenses. Brain oxidative stress (OS) estimated by lipid peroxidation (TBARS) and protein carbonyl were increased by lead. GA reversed the motor behavior parameters, the ALA-D activity, as well as the markers of OS changed by lead exposure. CAT activity remained high, possibly as a compensatory mechanism to eliminate hydroperoxides during lead poisoning. EDTA, a conventional chelating agent, was not beneficial on the lead-induced motor behavior and oxidative damages. Both GA (less) and EDTA (more) reduced the lead accumulation in brain tissue. Negative correlations were observed between the behavioral parameters and lipid peroxidation and the lead levels in brain tissue. In conclusion, GA may be an adjuvant in lead exposure, mainly by its antioxidant properties against the motor and oxidative damages resulting from such poisoning.


Subject(s)
Antioxidants/pharmacology , Behavior, Animal/drug effects , Brain/drug effects , Gallic Acid/pharmacology , Lead Poisoning, Nervous System/prevention & control , Motor Activity/drug effects , Oxidative Stress/drug effects , Animals , Brain/metabolism , Catalase/metabolism , Chelating Agents/pharmacology , Disease Models, Animal , Edetic Acid/pharmacology , Exploratory Behavior/drug effects , Lead , Lead Poisoning, Nervous System/metabolism , Lead Poisoning, Nervous System/physiopathology , Lead Poisoning, Nervous System/psychology , Lipid Peroxidation/drug effects , Male , Nitrates , Porphobilinogen Synthase/metabolism , Protein Carbonylation/drug effects , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL